4.7 Article

Activity of mecillinam against carbapenem-resistant Enterobacterales

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Emergence of VIM-producing Enterobacter cloacae complex in France between 2015 and 2018

Cecile Emeraud et al.

Summary: This study genetically characterized VIM-producing Enterobacter cloacae complex (ECC) isolates recovered in France from 2015 to 2018. The prevalence of ECC among VIM-producing Enterobacterales increased significantly during this period. Various species and sequence types were identified among these isolates. Additionally, different integrons carrying specific bla(VIM) variants were identified.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Letter Infectious Diseases

Activity of mecillinam against OXA-48-like carbapenemase-producing Enterobacterales

Athanasios Tsakris et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Article Microbiology

Susceptibility of Clinical Enterobacterales Isolates With Common and Rare Carbapenemases to Mecillinam

Frieder Fuchs et al.

Summary: The study found that mecillinam was effective against Enterobacterales producing IMI- and OXA-48-like carbapenemases, but there were issues with susceptibility testing using agar gradient diffusion and disk diffusion methods.

FRONTIERS IN MICROBIOLOGY (2021)

Article Microbiology

Results from a Prospective In Vitro Study on the Mecillinam (Amdinocillin) Susceptibility of Enterobacterales

Frieder Fuchs et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

Article Infectious Diseases

Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014

L. Dortet et al.

EUROSURVEILLANCE (2017)

Article Pharmacology & Pharmacy

Structural and Functional Aspects of Class A Carbapenemases

Thierry Naas et al.

CURRENT DRUG TARGETS (2016)

Article Pharmacology & Pharmacy

B1-Metallo-beta-Lactamases: Where Do We Stand?

Maria F. Mojica et al.

CURRENT DRUG TARGETS (2016)

Letter Infectious Diseases

In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase

Emma C. L. Marrs et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)

Review Infectious Diseases

OXA-48-like carbapenemases: the phantom menace

Laurent Poirel et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

Letter Infectious Diseases

Activity of mecillinam against ESBL producers in vitro

K Thomas et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)

Article Infectious Diseases

Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole

MB Kerrn et al.

CLINICAL MICROBIOLOGY AND INFECTION (2004)